Citi Pharma Limited (PSX: CPHL)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
46.62
-0.69 (-1.46%)
At close: Nov 14, 2024

Citi Pharma Balance Sheet

Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Sep '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019 - 2018
Cash & Equivalents
55.9187.954.6127.483,07489.44
Upgrade
Short-Term Investments
1,2661,2221,3931,660--
Upgrade
Trading Asset Securities
-108.81132.36312.12--
Upgrade
Cash & Short-Term Investments
1,3221,4181,5802,0003,07489.44
Upgrade
Cash Growth
-16.36%-10.25%-20.97%-34.96%3337.25%1.55%
Upgrade
Accounts Receivable
2,4402,1601,8821,402444.55299.47
Upgrade
Other Receivables
-203.2696.2945.77--
Upgrade
Receivables
2,4402,3631,9781,447444.55299.47
Upgrade
Inventory
3,6793,2032,6091,692778.19891.72
Upgrade
Other Current Assets
941.25590.48415.98458.15204.08113.1
Upgrade
Total Current Assets
8,3827,5756,5845,5974,5011,394
Upgrade
Property, Plant & Equipment
3,5353,5523,1222,2581,735814.46
Upgrade
Long-Term Investments
-----254.54
Upgrade
Long-Term Accounts Receivable
-20.2223.65-8.61-
Upgrade
Other Long-Term Assets
278.19254.54254.54272.06254.548.61
Upgrade
Total Assets
12,19511,4029,9848,1276,4992,471
Upgrade
Accounts Payable
4,0273,1841,9381,618993.58858.56
Upgrade
Accrued Expenses
56.25269.53206.62149.6758.5436.62
Upgrade
Short-Term Debt
1,4481,4371,768521.5712.2220.26
Upgrade
Current Portion of Long-Term Debt
11.8912.8655.88160.69108.7171.36
Upgrade
Current Portion of Leases
-5.425.674.772.996.6
Upgrade
Current Income Taxes Payable
606.24470.83393.19404.18126.8757.23
Upgrade
Current Unearned Revenue
-0.583.0414.515.860.45
Upgrade
Other Current Liabilities
1.39183.2282.1137.28526.77-
Upgrade
Total Current Liabilities
6,1515,5634,4533,0101,8361,251
Upgrade
Long-Term Debt
--8.54250.17189.16164.53
Upgrade
Long-Term Leases
--4.376.277.7613.87
Upgrade
Long-Term Unearned Revenue
--0.5832.179.270.57
Upgrade
Long-Term Deferred Tax Liabilities
-124.0994.2482.377.1755.84
Upgrade
Other Long-Term Liabilities
210.1----0-0
Upgrade
Total Liabilities
6,3615,7694,6113,4132,1331,493
Upgrade
Common Stock
2,2852,2852,2852,2851,350450
Upgrade
Additional Paid-In Capital
1,3921,3921,3921,392--
Upgrade
Retained Earnings
1,8491,6481,388728.54380.61528.31
Upgrade
Comprehensive Income & Other
309.29309.29309.29309.292,635-
Upgrade
Shareholders' Equity
5,8355,6335,3734,7144,366978.31
Upgrade
Total Liabilities & Equity
12,19511,4029,9848,1276,4992,471
Upgrade
Total Debt
1,4601,4551,843943.48320.81476.62
Upgrade
Net Cash (Debt)
-138.35-36.55-262.21,0562,754-387.18
Upgrade
Net Cash Growth
----61.65%--
Upgrade
Net Cash Per Share
-0.61-0.16-1.154.6614.77-3.91
Upgrade
Filing Date Shares Outstanding
228.46228.46228.46228.46148.599
Upgrade
Total Common Shares Outstanding
228.46228.46228.46228.46148.599
Upgrade
Working Capital
2,2312,0132,1312,5862,666142.66
Upgrade
Book Value Per Share
25.5424.6623.5220.6329.409.88
Upgrade
Tangible Book Value
5,8355,6335,3734,7144,366978.31
Upgrade
Tangible Book Value Per Share
25.5424.6623.5220.6329.409.88
Upgrade
Land
-1,8651,8651,4211,049-
Upgrade
Buildings
-661.56485.03309.33214.96-
Upgrade
Machinery
-1,5251,194915.01795.57-
Upgrade
Construction In Progress
-152.670.3914.33--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.